Harvard Bioscience, Inc.
HBIO
$5.37
-$0.18-3.24%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -2.85M | -1.23M | -2.28M | -50.34M | 18.00K |
| Total Depreciation and Amortization | 1.35M | 1.32M | 1.62M | 1.66M | 1.76M |
| Total Amortization of Deferred Charges | 624.00K | 357.00K | 210.00K | 131.00K | 98.00K |
| Total Other Non-Cash Items | 1.70M | 344.00K | 422.00K | 48.03M | 442.00K |
| Change in Net Operating Assets | -918.00K | 290.00K | 2.79M | 3.51M | -593.00K |
| Cash from Operations | -96.00K | 1.08M | 2.76M | 2.99M | 1.73M |
| Capital Expenditure | -449.00K | -207.00K | -89.00K | -513.00K | -301.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -150.00K | -141.00K | -144.00K | -170.00K | -165.00K |
| Cash from Investing | -599.00K | -348.00K | -233.00K | -683.00K | -466.00K |
| Total Debt Issued | 40.00M | -- | -- | -- | 0.00 |
| Total Debt Repaid | -34.35M | -1.00M | -1.00M | -1.00M | -1.00M |
| Issuance of Common Stock | 1.00K | 0.00 | 46.00K | -- | 161.00K |
| Repurchase of Common Stock | -57.00K | -24.00K | 0.00 | -75.00K | -518.00K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -3.15M | -254.00K | -304.00K | -129.00K | 0.00 |
| Cash from Financing | 2.45M | -1.28M | -1.26M | -1.20M | -1.36M |
| Foreign Exchange rate Adjustments | 43.00K | -83.00K | 632.00K | 339.00K | -363.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 1.80M | -625.00K | 1.90M | 1.44M | -461.00K |